Patient Compliance
Patient Compliance - Related Videos
10:19
Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
0 Views •
Cited by 23 •
2014
Exercise may alleviate behavioral impairments associated with neurodegenerative diseases. Studies of the mechanisms underlying exercise-mediated effects have increased in disease models, but the neurobiological background accompanying these diseases, specifically aging, is likely not considered. Here, we illustrate measures to increase the likelihood of a successful exercise paradigm in aged rats.
07:53
Quantifying Inferior Vena Cava Compliance and Distensibility in an In Vivo Ovine Model Using 3D Angiography
0 Views •
Cited by 2 •
2024
This protocol allows for the in vivo quantification of venous compliance and distensibility using catheterization and 3D angiography as a survival procedure allowing for a variety of potential applications.
08:10
Proper Adjustment of Patient Attire during the Physical Exam
0 Views •
2023
Source: Jaideep S. Talwalkar, MD, and Joseph Donroe, MD, Internal Medicine and Pediatrics, Yale School of Medicine, New Haven, CT In order to optimize the predictive value of the physical examination, the provider must perform maneuvers correctly. The proper use of drapes is an important component of correctly performing physical examination maneuvers. Skin lesions are missed when "inspection" occurs through clothing, crackles are erroneously reported when the lungs are examined through a...
05:45
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
0 Views •
Cited by 10 •
2017
This protocol was developed to quantitatively identify tumor microenvironment components in glioblastoma patient resections using chromogenic immunohistochemistry and ImageJ.
08:40
Methyl-binding DNA capture Sequencing for Patient Tissues
0 Views •
Cited by 1 •
2016
Here we present a protocol to investigate genome wide DNA methylation in large scale clinical patient screening studies using the Methyl-Binding DNA Capture sequencing (MBDCap-seq or MBD-seq) technology and the subsequent bioinformatics analysis pipeline.
FAQs
A missed dose can reduce the amount of medicine available for the body to use, while irregular timing can disrupt the intended dosing interval. These changes may lower or destabilize plasma concentrations, making it harder for the drug to reach or remain within therapeutic levels. Pharmacologists therefore consider dosing patterns when evaluating whether a treatment has produced an inadequate response.
Taking the correct total number of doses does not always preserve the intended exposure pattern. When doses occur too close together or too far apart, plasma concentrations may differ from those expected under the prescribed regimen. This timing-related variation can complicate interpretation of treatment response and may make an apparently ineffective medicine difficult to assess accurately.
A poor clinical response does not necessarily mean that the medicine lacks effectiveness. Pharmacologists and healthcare professionals examine whether doses, intervals, and treatment duration were followed before attributing the outcome to medication failure. This distinction improves interpretation of treatment response by separating problems with drug effectiveness from insufficient or inconsistent exposure caused by inadequate use.
Assessment should address whether the prescribed doses were taken at the intended times and whether treatment continued for the recommended duration. The resulting pattern can then be considered alongside treatment response and expected drug exposure. This approach helps identify whether missed doses, altered intervals, or early cessation may explain plasma concentrations or outcomes that differ from those anticipated.
Clear instructions and patient counseling can help people understand how to follow the prescribed regimen. Simplifying the regimen may also make the dosing schedule easier to maintain, while follow-up provides an opportunity to review ongoing use and treatment response. Together, these measures support patient-centered care and can improve the likelihood that medicines produce their intended therapeutic effect.
Compliance affects how reliably a study reflects the medicine's actual treatment effects. If participants miss doses, alter intervals, or stop early, their drug exposure may differ from the planned regimen, complicating interpretation of outcomes. Monitoring and supporting adherence therefore strengthens the reliability of clinical research findings and helps investigators evaluate therapeutic effectiveness more accurately.